75F40122C00181

CALIBRATING RWE STUDIES IN ONCOLOGY AGAINST RANDOMIZED TRIALS

Food and Drug Administration · United States

This tender closed on Friday, January 29, 2027. Browse open opportunities

View Source

Time Left to Bid

Closed

ClosedHealthcare & MedicalFederal

Basic information

Reference number: 75F40122C00181
Issuing organization: Food and Drug Administration · Find award history →
Government level: Federal
Solicitation type: Healthcare & Medical
Title: CALIBRATING RWE STUDIES IN ONCOLOGY AGAINST RANDOMIZED TRIALS
Source: USASpending (Federal)
Source ID: usa-75F40122C00181

Details

Location: United States

Description

CALIBRATING RWE STUDIES IN ONCOLOGY AGAINST RANDOMIZED TRIALS Awarded to: BRIGHAM & WOMENS HOSPITAL INC Agency: Department of Health and Human Services Sub-agency: Food and Drug Administration Award type: DEFINITIVE CONTRACT

Dates

Publication: 2022/09/21 12:00:00 AM UTC
Closing date: 2027/01/29 12:00:00 AM UTC

Estimated value

$3.7M USD

Classification

Normalized category

Healthcare & Medical

Source: USASpending (Federal)

Last updated 2026-09-02, 12:10:54 p.m.

Data refreshed every 2 hours